Showing 1 - 10 results of 10 for search 'Jhanelle E Gray', query time: 0.82s
Refine Results
-
1
-
2
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy by Dung-Tsa Chen, Andreas N. Saltos, Trevor Rose, Zachary J. Thompson, Ram Thapa, Alberto Chiappori, Jhanelle E. Gray
Published 2023-04-01
Article -
3
-
4
High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer by Yumeng Zhang, Lancia Darville, Stephanie Hogue, Julie E. Hallanger Johnson, Trevor Rose, Youngchul Kim, Alexis Bailey, Jhanelle E. Gray, Lary A. Robinson
Published 2024-03-01
Article -
5
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189 by Shirish Gadgeel, MD, Jhanelle E. Gray, MD, Maria Teresa Rizzo, MD, Patrick Peterson, PhD, Jong Seok Kim, MD, Delvys Rodríguez-Abreu, MD, PhD
Published 2022-11-01
Article -
6
Qualitative Findings From a Survey on Patient Experiences and Satisfaction with Lung Cancer Screening by Jaileene Pérez-Morales PhD, Rashmi Pathak, Monica Reyes PhD, Haley Tolbert MHA, Rajwantee Tirbene, Jhanelle E. Gray MD, Vani N. Simmons PhD, Matthew B. Schabath PhD, Gwendolyn P. Quinn PhD
Published 2023-03-01
Article -
7
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer by Juliann Chmielecki, Jhanelle E. Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J. Carl Barrett, Ryan J. Hartmaier, Suresh S. Ramalingam
Published 2023-02-01
Article -
8
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer by Juliann Chmielecki, Jhanelle E. Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J. Carl Barrett, Ryan J. Hartmaier, Suresh S. Ramalingam
Published 2023-06-01
Article -
9
629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and... by Hong Zheng, Uzma Khan, Xiaofei Wang, Xiaoqing Yu, Georgia M Beasley, James Ronald, Jhanelle E Gray, Scott J Antonia, Steven Wolf, Neal E Ready, Bruna Pellini, Andreas N Saltos, Christy Arrowood, Ghassan El-Haddad, Tawee Tanvetyanon, Luiziane Guerra-Guevara, Lin Gu, Dana Foresman, Mark J Cantwell, Amer A Beg
Published 2023-11-01Article -
10
Replicative Instability Drives Cancer Progression by Benjamin B. Morris, Jason P. Smith, Qi Zhang, Zhijie Jiang, Oliver A. Hampton, Michelle L. Churchman, Susanne M. Arnold, Dwight H. Owen, Jhanelle E. Gray, Patrick M. Dillon, Hatem H. Soliman, Daniel G. Stover, Howard Colman, Arnab Chakravarti, Kenneth H. Shain, Ariosto S. Silva, John L. Villano, Michael A. Vogelbaum, Virginia F. Borges, Wallace L. Akerley, Ryan D. Gentzler, Richard D. Hall, Cindy B. Matsen, C. M. Ulrich, Andrew R. Post, David A. Nix, Eric A. Singer, James M. Larner, Peter Todd Stukenberg, David R. Jones, Marty W. Mayo
Published 2022-10-01
Article